Cohance to invest $10 million to expand cGMP bioconjugation capabilities in US
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Subscribe To Our Newsletter & Stay Updated